brivanib alaninate (BMS-582664) / BMS, ZAI Lab  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
brivanib alaninate (BMS-582664) / ZAI Lab
CQGOG0101, NCT04395612: Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

Recruiting
2
38
RoW
niraparib combined with brivanib, Treatment group1, niraparib combined with toripalimab, Treatment group2
Chongqing University Cancer Hospital
Cervical Cancer
04/22
07/22

Download Options